Use of Geospatial Modeling to Predict Schistosoma mansoni Prevalence in Nyanza Province, Kenya

Distinct Schistosoma mansoni-Specific Immunoglobulin Subclasses Are Induced by Different Schistosoma mansoni Stages—A Tool to Decipher Schistosoma mansoni Infection Stages

Despite the existence of an effective medication against schistosomiasis, the disease remains a majo

<i>Schistosoma mansoni</i> in Tanzania and Kenya.

Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in Uganda and Mali

Abstract Background Understanding whether schistosomiasis control programmes are on course to contro

Prevalence Mapping of Schistosoma mansoni Among Pre-school Age Children in Rwanda

Schistosoma mansoni is endemic in Rwanda, and control programs have been implem

Direct measurement of in vitro response to Praziquantel in Schistosoma mansoni populations from Western Kenya

Large-scale treatment with praziquantel (PZQ) monotherapy is used to control schistosomiasis, leadin

Additional file 1: of Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in Uganda and Mali

Markov model equations, model parameters and additional tables and figures. Text S1. Markov model fo